The impact of elevated cardiovascular disease risk (i.e., elevated CRP levels) and increased risk of hemochromatosis that appears to be evident with prolonged use of synthetic reproductive hormones by premenopausal females is an area of health and exercise performance research that remains to be investigated. Here, CRP is linked to hemochromatosis type 1.